[Neuroleptic malignant syndrome (dopamine-dependent malignant hyperthermia). 4 different cases].
D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects*; D001971:Bromocriptine / Q000627:therapeutic use; D003620:Dantrolene / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy / Q000209:etiology*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D011954:Receptors, Dopamine / Q000187:drug effects*; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D011954:Receptors, Dopamine; D001971:Bromocriptine; D003620:Dantrolene
Das neuroleptische maligne Syndrom (dopaminabhängige maligne Hyperthermie). Vier differente Fälle.